AMMA is a multidisciplinary Association, born in 2011, to promote antiaeging medicine in the Principality of Monaco.

Antiaeging medicine

Antiaeging medicine is the personalized, preventive and global medicine aiming at early detection of acquired and/or genetic predispositions and symptoms of the aging in order to propose adapted cares.

It dwells at the detection of the weaknesses to avoid further dependence. 

Antiaeging medicine, even if it includes it, is not to be confused with aesthetic medicine.

Our Goals​
  • Public awareness to a preventive medicine for a better aeging;
  • Organization of conferences with high-level scientist speakers in the diverse topics of aeging science;
  • Organization of congresses and seminars for doctors, pharmacists and paramedical professionals;
  • Capacity-building for the members of the Association in the innovative domains of antiaeging medicine;
  • Setting up of a coordinate antiaeging consultation.

Discovering the intestinal microbiota

Conférence débat

in French

Pr Philippe Marteau

APHP.Sorbonne University

Hepato-Gastroenterology Department, St Antoine Hospital

Auditorium du Lycée Technique et Hôtelier- MONACO

jeudi 28 novembre 2019 à 19 h

entrée libre

   The man is a holobionte who lives in symbiosis with microorganisms (the microbiota ), especially in his digestive tract. These microorganisms exert physiological functions important for the digestive system but also the host in general including his brain and his immune system.

   Disturbances of one of the elements of symbiosis (host and microbiota ) generally affect the other and health. Such dysbiosis have been described recently in many diseases of the digestive system and liver.

   As with most ecosystems, the richness and biodiversity of the gut microbiota are factors that promote its stability, strength and resilience .  

   In this presentation, I will discuss 

  • The big current concepts of intestinal ecology, a real scientific revolution;

  • Examples of dysbiosis observed during antibiotic treatments, infections, acute or chronic diseases of the digestive tract, but also obesity and inflammatory or neurological diseases.

·  And summarize the therapeutic applications by showing that we went from the sole antibiotic therapy to modulate the ecosystem to approaches intended to correct the rupture of host-microbiota symbiosis by contributions of new micro-organisms: Rebiosis , fecal transplantation, probiotics and / or substrates such as fibers and prebiotics .